 |
Polyphenyl(disodium 3-O-sulfo-beta-D-glucopyranuronate)-(1?3)-beta-D-galactopyranoside |
|---|---|
| Trade Name | |
| Orphan Indication | Anti-MAG neuropathy |
| EU Market Approval | EU |
| EU Designation Date | 2017-07-17 00:00:00 |
| Sponsor | SFL Regulatory Affairs Consulting Ltd |
| |
Polyphenyl(disodium 3-O-sulfo-beta-D-glucopyranuronate)-(1?3)-beta-D-galactopyranoside |
|---|---|
| Trade Name | |
| Orphan Indication | Anti-MAG neuropathy |
| EU Market Approval | EU |
| EU Designation Date | 2017-07-17 00:00:00 |
| Sponsor | SFL Regulatory Affairs Consulting Ltd |